Related Experiment Video
Updated: Jul 3, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Parkinson's disease progression is multifaceted: Evidence for the underlying benchmarks
1Department of Neurology, Mayo Clinic, Rochester, MN, 55905, USA.
Parkinson's disease (PD) progression varies significantly between individuals over time. Understanding these diverse progression patterns is crucial for effective patient care and future research strategies.
Area of Science:
- Neurology
- Neuroscience
- Movement Disorders
Background:
- Parkinson's disease (PD) is characterized by progressive neurodegeneration.
- Individual PD progression trajectories are highly variable.
- Recognizing progression milestones is essential for clinical management.
Purpose of the Study:
- To highlight the heterogeneous nature of long-term Parkinson's disease progression.
- To emphasize the importance of identifying progression benchmarks and their underlying biological substrates.
- To inform patient expectations and guide PD research planning.
Main Methods:
- This study is a review and conceptual analysis.
- It synthesizes current understanding of PD progression.
- It discusses the implications for clinical practice and research.
Main Results:
- Parkinson's disease progression is not uniform.
- Diverse manifestations and timelines exist for PD.
- Identifying specific progression markers is key.
Conclusions:
- Acknowledging the heterogeneity of Parkinson's disease progression is vital.
- Understanding progression substrates will improve treatments and patient support.
- This knowledge is critical for strategic planning in PD research.
More Related Videos
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
08:11Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
Published on: November 14, 2016
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Neural Regulation